about
Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disordersPharmacological treatment of anxiety disorders: current treatments and future directionsImproving Outcome of Psychosocial Treatments by Enhancing Memory and Learning.The Future of D-Cycloserine and Other Cognitive Modifiers in Obsessive-Compulsive and Related DisordersOpposing effects of D-cycloserine on fear despite a common extinction duration: interactions between brain regions and behavior.D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorderD-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders.D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variablesA randomized controlled trial of cognitive remediation and d-cycloserine for individuals with bipolar disorder.Inhibiting glycine transporter-1 facilitates cocaine-cue extinction and attenuates reacquisition of cocaine-seeking behavior.The effect of D-cycloserine on subliminal cue exposure in spider fearful individuals.D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia.Augmentation of exposure therapy with post-session administration of D-cycloserine.D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessionsA biopsychosocial model based on negative feedback and control.Mathematics Anxiety, Working Memory, and Mathematics Performance in Secondary-School Children.Vagus Nerve Stimulation Enhances Extinction of Conditioned Fear in Rats and Modulates Arc Protein, CaMKII, and GluN2B-Containing NMDA Receptors in the Basolateral Amygdala.The future of therapygenetics: where will studies predicting psychological treatment response from genomic markers lead?
P2860
Q24187995-BE191A8D-4F2C-4CDD-B8E9-BD86C963D769Q26851461-B66F6DE4-E1B3-4745-90EA-621D6267D696Q30417837-F1C78087-430F-472E-B8CA-0191C554144CQ30426498-9B1441D8-520E-4672-BB7F-3B18BBA821BAQ33740875-2A8B5FC0-029A-44BA-A75A-7EAC57F94313Q33760626-CAB7EF7A-622E-42EE-AE2A-5031D785969EQ34350942-A2BA7C77-E0C3-40F1-A494-8BA2B30719E6Q34562562-1E8BDF48-D5B0-4E53-A4FF-34247D684EAFQ34729257-24A0472B-C842-4144-B674-D0021B15F9FCQ35783002-61E6CE7A-7007-4120-A926-1CBD70FFAB3FQ36456733-0D7C059D-7816-4AC2-826B-45AC749DC5C5Q36794617-73C1B026-6097-479F-96B2-7F399208BE04Q37066267-79D17EC0-6168-4D90-8FF7-B602214E67C1Q37106723-755FFF08-6AFC-473E-A253-6EA1DCE4B899Q38195037-59545BFC-7CFB-4877-82FD-9776A228F5E0Q42151237-B4F8D9BC-B3E9-4342-AE41-818C077D3459Q42364462-0E8AE3EF-AF4D-4E16-A30C-302F4057DEC6Q48827904-E7EC7734-7C40-46B7-86C6-5B5785108FCE
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cognitive enhancers for anxiety disorders.
@en
type
label
Cognitive enhancers for anxiety disorders.
@en
prefLabel
Cognitive enhancers for anxiety disorders.
@en
P2860
P50
P1476
Cognitive enhancers for anxiety disorders.
@en
P2093
Anu Asnaani
Jasper A J Smits
P2860
P304
P356
10.1016/J.PBB.2010.11.020
P407
P577
2010-12-04T00:00:00Z